Vildagliptin 50 MG

DRUG12 trials

Conditions

Coronary Artery DiseaseDiabetes MellitusDiabetes Mellitus, Type 2DyslipidemiasHealthyMajor Depressive DisorderPoly Cystic Ovary SyndromeReducing the Elevated Blood Pressure for Diabetic Hypertensive Patients

Phase 1

A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)

CompletedNCT01582308

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2012-06-21End: 2012-12-14Updated: 2017-05-30

The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients

WithdrawnNCT04410341

Sadat City UniversityMajor Depressive Disorder

Start: 2020-05-01End: 2024-12-01Updated: 2025-07-14

Phase 2

Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

WithdrawnNCT04761861

Sadat City UniversityDyslipidemias, Schizophrenia

Start: 2021-02-16End: 2025-12-31Updated: 2025-07-14

Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome

RecruitingNCT06142656

October 6 UniversityPoly Cystic Ovary Syndrome

Start: 2023-11-25End: 2026-02-01Target: 60Updated: 2025-07-30

Phase 4

Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

CompletedNCT03253562

MTI UniversityReducing the Elevated Blood Pressure for Diabetic Hypertensive Patients

Start: 2017-02-01End: 2017-08-01Updated: 2017-08-18

Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes

CompletedNCT04916093

Beni-Suef UniversityDiabetes Mellitus, Type 2

Start: 2019-12-20End: 2020-12-15Updated: 2021-06-07

Unknown Phase

Vildagliptin on Gastric Accommodation

CompletedNCT03500900

Universitaire Ziekenhuizen KU LeuvenHealthy

Start: 2016-03-01End: 2017-01-01Updated: 2018-04-18

The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safeyt Profile of Test Product Compared to Reference Product Will be Assessed.

CompletedNCT05329844

AET Laboratories Private LimitedDiabetes Mellitus

Start: 2014-02-28End: 2015-04-30Updated: 2022-04-15

Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients

CompletedNCT06068686

Damanhour UniversityType 2 Diabetes

Start: 2022-10-01End: 2024-12-01Updated: 2025-02-04

Empagliflozin Versus Vildagliptin in CAD Patients With T2DM

CompletedNCT06313008

Damanhour UniversityCoronary Artery Disease, Type 2 Diabetes

Start: 2023-08-10End: 2024-10-10Updated: 2024-11-29

Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes

Active, not recruitingNCT06889909

Lahore General HospitalType 2 Diabetes Mellitus (T2DM)

Start: 2024-12-15End: 2025-06-15Updated: 2025-03-21

Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes

Active, not recruitingNCT06913101

PNS Hafeez - Naval HospitalType 2 Diabetes Mellitus (T2DM)